---
title: 'Pre-emptive Montelukast and Its Effect on Clinical Outcomes After Mandibular Third Molar Surgery: A Triple-blinded Randomized Controlled Trial'
date: 2025-07-03T06:57:18.097437

draft: false
---

### AI 리뷰 생성 실패
오류: 429 You exceeded your current quota, please check your plan and billing details. For more information on this error, head to: https://ai.google.dev/gemini-api/docs/rate-limits. [violations {
  quota_metric: "generativelanguage.googleapis.com/generate_content_free_tier_requests"
  quota_id: "GenerateRequestsPerDayPerProjectPerModel-FreeTier"
  quota_dimensions {
    key: "model"
    value: "gemini-1.5-flash"
  }
  quota_dimensions {
    key: "location"
    value: "global"
  }
  quota_value: 50
}
, links {
  description: "Learn more about Gemini API quotas"
  url: "https://ai.google.dev/gemini-api/docs/rate-limits"
}
, retry_delay {
  seconds: 41
}
]

---

#### 원문 초록 (Original Abstract)
Cyclooxygenase inhibitors are well-studied for pain and swelling control after mandibular third molar extraction, while the lipoxygenase pathway and leukotriene receptor antagonists, like montelukast, remain less researched.

<br>

**[원문 바로가기](https://www.joms.org/article/S0278-2391(25)00238-1/fulltext?rss=yes)**
